Stocks and Investing
Stocks and Investing
Mon, January 11, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sun, January 10, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, January 8, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Paul Knight Maintained (AVNS) at Buy with Increased Target to $55 on, Jan 8th, 2021
Paul Knight of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Increased Target from $47 to $55 on, Jan 8th, 2021.
Paul has made no other calls on AVNS in the last 4 months.
There are 2 other peers that have a rating on AVNS. Out of the 2 peers that are also analyzing AVNS, 0 agree with Paul's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Paul
- David Lewis of "Morgan Stanley" Maintained at Sell with Increased Target to $45 on, Tuesday, December 15th, 2020
- Matthew Mishan of "Keybanc" Maintained at Buy with Increased Target to $47 on, Wednesday, November 4th, 2020
Contributing Sources